Biostatistics

Home | Research Accomplishments | Services & Requests | Equipment and Software | Authorship Policy

 

Mission

The primary mission of BSR is to enhance the scientific rigor of all Rutgers Cancer Institute research across the translational continuum by providing mathematical rigor and trial design accessible to Rutgers Cancer Institute members.

 

Personnel

Hao Liu, PhD, joined Rutgers Cancer Institute in July 2021 and serves as the Director of BSR and is a Professor of Biostatistics at Rutgers School of Public Health (SPH). Liu has expertise in statistical designs of early-phase clinical trials and basic and population science studies. He has published more than 120 papers in peer-reviewed journals and has served as co-investigator on numerous NIH-funded trials, on the editorial boards of J Clin Oncol and J Natl Cancer Inst, and NIH and DOD study sections.

Yong Lin, PhD, is a Professor of Biostatistics at Rutgers SPH and an expert in Phase I and II clinical trials, statistical analysis of laboratory animal experiments, and population research. Lin is an expert in Phase I and II clinical trials, with 39 publications over the last grant period. He has been a co-investigator on 17 grants from NIH/NCI, ACS, and LLS (six over the last grant period).

Dirk Moore, PhD, is an Associate Professor of Biostatistics at Rutgers SPH. He was previously at Temple University, where he collaborated with Fox Chase Cancer Center researchers. He received his MS in biology from Yale University, his PhD from the University of Washington, and completed a post-doctoral fellowship at the Harvard School of Public Health. He has published over 100 publications and is the author of the highly cited book "Applied Survival Analysis Using R.

Elizabeth Handorf, PhD,  is an Associate Professor of Biostatistics at Rutgers SPH.
She was recruited to the Rutgers Cancer Institute in 2023 to support the statistical design and analysis of interventional and epidemiological studies in cancer, statistical methods for observational cancer studies using electronic health records, cancer registries, and insurance claims, and to support cost and cost-effectiveness analysis.

Shou-en Lu, PhD and Pamela Ohman-Strickland, PhD, are Associate Professors of Biostatistics with expertise in designing and implementing randomized trials, panel studies, epidemiological cohort and case-control studies, and the design and analysis of population-based randomized controlled trials (RCT) including clustered RCTs for the CPC program.

The BSR also includes staff Statistician/Data Analyst & Programmer Chunxia Chen, and staff Principal Statisticians Shengguo Li and Fan Ling

 

PUBLICATION ACKNOWLEDGEMENT 

"Services, results, and/or products in support of the research project were generated by the Rutgers Cancer Institute Biostatistics Shared Resource, supported, in part, with funding from NCI-CCSG P30CA072720-6852."

Please consider including the names of individuals from the shared resource if they provided any intellectual input or additional effort.

NIH Public Access Policy: Publications that result from services provided by this Shared Resource must be compliant with the NIH Public Access policy by submitting your paper to PubMed Central. Go to: https://publicaccess.nih.gov/submit_process.htm for PubMed Central's submission methods instructions.  

If you require additional guidance on how to properly acknowledge a single shared resource or multiple shared resources, you may contact Janet Bandoy, Shared Resources Coordinator.

 

Last updated 02/01/2023